GE Healthcare, the healthcare business of General Electric Company, forays into the home healthcare market in India through the introduction of sleep care and home respiratory care solutions, that are added through acquisition of Vital Sign. The home health solutions are added through acquisition of Vital Signs Inc and its subsidiary Breas Medical AB.
Vital Signs is a provider of medical products applicable to a wide range of care areas such as anesthesia, respiratory, sleep therapy and emergency medicine. Vital Signs has a broad product portfolio of innovative single-patient use products which offer significant cost advantages and improved patient care features, including reducing the likelihood of transmitting infections from one patient to another. Single patient-use technologies contribute to a reduction in patient mortality through limiting hospital-acquired infections. Vital Signs products will highly complement GE Healthcares leading anesthesia delivery, patient monitoring and acute respiratory offerings.
“Home Healthcare is largely untapped, while at the same time, a fast growing market in India. This global acquisition is consistent with GE’s strategy to invest in high technology, innovative businesses that deliver top-line growth and earnings expansion. This acquisition takes us one step closer to our vision Early Health. It is a strong, strategic fit and allows us to address the individual patient directly, for the first time. This is our first foray into home health in India, said Mr V Raja, President and CEO, GE Healthcare South Asia.
“At GE Healthcare we are very pleased to enter the home health and sleep care market. As a company we look for strategic ways to strengthen the breadth and depth of our product portfolio in response to customers needs. Moreover, now with our iSleep products, we continue to provide clinicians solutions for better patient care with the aim to improve patient quality of life,” said Mr S Ganesh Prasad, Vice President Clinical Systems, GE Healthcare, India.